Thought this would be an important story to share, especially with all of our member s currently getting checked out! Taken from cp24.com
Passing The Test
Itâ€[emoji]8482[/emoji]s not the kind of thing you hear often in the same sentence. Cancer and good news. But Canadian researchers had the latter about the former Thursday, when a study about a new drug proved so successful it was stopped early, so all patients could take advantage of the therapy.
The miracle substance is called Letrozole or Femara, and it appears to prevent the disease from returning in post-menopausal women. At least 5,000 women around the world took part in the tests. And the results were dramatic. Those taking the drug had almost half the number of cancer recurrences than those on placebos.
Up until now, patients had to take Tamoxifen to prevent a reoccurrence of the disease. But they could only stay on it for five years. “The results from this study indicate now we have something following that five-year period,†an excited Dr. James Ingle reveals. “The magnitude of the benefit was so significant that, in fact, this trial was stopped very early.â€
The drug stops the mechanism that produces estrogen, and winds up starving the cancer cells. Itâ€[emoji]8482[/emoji]s already made a difference in the life of patients like Kathy Anderson. “Just to know that … there's another medication after Tamoxifen … that your chance of breast cancer recurrence has been cut in half, that's major. It's very important.â€
Doctors now believe any woman past the Tamoxifen cycle should be put on the new drug, although researchers admit they still arenâ€[emoji]8482[/emoji]t sure how long it can be taken. They recommend you talk to your family doctor or call the Canadian Cancer Society at 1-888-939-3333 for more information.
To see unedited video of Ingle and Anderson on the breakthrough, click here.
October 9, 2003
Passing The Test
Itâ€[emoji]8482[/emoji]s not the kind of thing you hear often in the same sentence. Cancer and good news. But Canadian researchers had the latter about the former Thursday, when a study about a new drug proved so successful it was stopped early, so all patients could take advantage of the therapy.
The miracle substance is called Letrozole or Femara, and it appears to prevent the disease from returning in post-menopausal women. At least 5,000 women around the world took part in the tests. And the results were dramatic. Those taking the drug had almost half the number of cancer recurrences than those on placebos.
Up until now, patients had to take Tamoxifen to prevent a reoccurrence of the disease. But they could only stay on it for five years. “The results from this study indicate now we have something following that five-year period,†an excited Dr. James Ingle reveals. “The magnitude of the benefit was so significant that, in fact, this trial was stopped very early.â€
The drug stops the mechanism that produces estrogen, and winds up starving the cancer cells. Itâ€[emoji]8482[/emoji]s already made a difference in the life of patients like Kathy Anderson. “Just to know that … there's another medication after Tamoxifen … that your chance of breast cancer recurrence has been cut in half, that's major. It's very important.â€
Doctors now believe any woman past the Tamoxifen cycle should be put on the new drug, although researchers admit they still arenâ€[emoji]8482[/emoji]t sure how long it can be taken. They recommend you talk to your family doctor or call the Canadian Cancer Society at 1-888-939-3333 for more information.
To see unedited video of Ingle and Anderson on the breakthrough, click here.
October 9, 2003
